Stopping GLP-1 drugs often brings weight back. A small trial suggests ways to slow it
A recent study published in Obesity Science & Practice investigated whether medically tailored meals or digital wellness apps could help mitigate weight regain after patients stop taking GLP-1 receptor agonists. The research highlights the role of these dietitian-designed meal interventions in supporting long-term weight management for individuals transitioning off obesity medications.
HNH Insight
This article connects the emerging use of medically tailored meals to the clinical challenge of weight regain following the discontinuation of popular GLP-1 medications, emphasizing the role of structured nutritional support.
Exchange Discussion
Join the expert conversation on this article in the HN&H Intelligence Exchange. Professional discussion only — cite your sources.
No comments yet.
